Scott Braunstein, CHAIRMAN AND CEO at MARINUS PHARMACEUTICALS, INC. (MRNS), bought 5,933 shares at $1.10 ($7K) on 2024-08-14, disclosed to the SEC on 2025-02-11.
Scheduled purchase ($7k) by CHAIRMAN AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MRNS | SELL | 2023-08-08 | $123K | — | Filing → |
| MRNS | BUY | 2019-12-13 | $125K | — | Filing → |
| PCRX | SELL | 2017-06-07 | $33K | — | Filing → |